Bachelor’s Degree (Biology) – University of South Florida

Training Associate – Bristol-Myers Squibb (launched PSSIII selling skills program to full sales force)

VP Sales, First Horizon:  personally launched new selling skills program (SI-2000), along with Director of Training, to entire sales force

Multiple regional & national sales leadership positions: BMS, First Horizon, Eyetech, Takeda – in each role, played an active role in the development (personal and career) of management teams and developmental/promotable representatives, including leading ‘leadership’ workshops, group development workshops & programs.
 
Consultant – Strategic HealthCare Resources, LLC: lead customized Leadership workshops

Mike Leone is recognized as an accomplished pharmaceutical sales executive with broad therapeutic expertise that drives performance.  His over 25 years of experience and leadership includes positions of increasing responsibility at Bristol-Myers Squibb, First Horizon Pharmaceuticals, Eyetech Pharmaceuticals and Takeda Pharmaceuticals North America.  He is currently President of Strategic HealthCare Resources, LLC, and is consulting for a number of venture capital, pharmaceutical, biotech and device companies in strategic and leadership roles.  One of his most noteworthy contributions was reorganizing a major biotech company’s Managed Care organization and developing the template for their hospital sales force, both of which are in use today.  He has helped companies create sales force deployment models, developed compensation models, served as a direct customer liaison with state Medicaid and federal government customers on formulary and pharmacoeconomic issues, consulted on clinical trial focus areas, conducted focused leadership training programs, and added structure and leadership expertise to a growing sales organization.

Spending the majority of his career at Bristol-Myers Squibb, Mike held numerous positions of increasing responsibility.  These positions included National Director, Federal & Institutional Sales, a position in which he rebuilt the Hospital Sales Team and strengthened BMS’ role and commitment to the VA and military customers.  During this time, Mike developed the mission and revitalized the morale of the 275 BMS Hospital Managers and Representatives, and spearheaded the launch of Maxipime, the first fourth-generation cephalosporin antibiotic, and Plavix, a platelet anti-clotting agent, in co-promotion with Sanofi-Aventis.  He also oversaw the contractual relationship with Innovex, for community hospital representatives.  Prior to that position, Mike was a National Accounts Director, where he developed and coordinated major account contracts and support programs for the range of BMS corporate products, and Eastern Region Director for the Bristol-Myers Squibb Hospital & Institutional Sales Group, where he successfully led his team to achieve and exceed their goals in every year of the Group’s existence. 

After a brief consulting role with a major biotech organization, Mike became National Sales Director and then Vice President of Sales at First Horizon Pharmaceutical Corporation, where he successfully led the sales force expansion resulting in a 60% growth in revenues.  Mike then joined Eyetech, a specialty biotech company, as their National Sales Director.  In this role, he led all facets of the sales force operations and infrastructure development, including sales strategy, alignment, sales force automation and budgeting.  Shortly after leaving Eyetech, Mike joined Takeda Pharmaceuticals as the Mid-Atlantic South Regional Sales Director.  Praised for his leadership, coaching and functional skills, he led the Region to an impressive 106% of goal through the mid-year point of fiscal 2005, attaining the #1 ranking for his region.

Mike has broad therapeutic experience in categories such as cardiovasculars, psychotherapeutics, community and hospital anti-infective’s, ophthalmology, and diabetes.

Mike earned a Bachelor’s Degree in Biology from the University of South Florida.  He has also attended numerous executive education courses at the Wharton, Darden and Kellogg Schools of Business. 

He has also been recognized in multiple editions of “Who’s Who”.